Patents by Inventor Richard Mears

Richard Mears has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9669909
    Abstract: The water spray cooling device for a watercraft includes at least one water sprayer that is adaptively secured to a watercraft. The one or more water sprayers are in fluidic communication with a pump via a first conduit. The pump is in fluidic communication with an intake valve via a second conduit. The intake valve is located on a hull of the watercraft in order to collect water, which is then transferred to the pump. The one or more water sprayers spray water onto an occupant of the watercraft. The one or more water sprayers are ideally located on an external surface of the watercraft in order to direct water at a driver of the watercraft.
    Type: Grant
    Filed: December 27, 2016
    Date of Patent: June 6, 2017
    Inventor: Richard Mear
  • Publication number: 20170096446
    Abstract: The present invention concerns novel pharmaceutically active triterpene derivatives, pharmaceutical compositions containing the same, their use as medicaments, and the use of the compounds for the manufacture of specific medicaments. The present invention also concerns a method of treatment involving administration of the compounds. Specifically, the compounds are derivatives of betulinic acid having substitutions at one or more of the C-3, C2-8 and C-19 positions as further described herein. The novel compounds are useful as antiretroviral agents. In particular, the novel compounds are useful for the treatment of Human Immunodeficiency Virus (HIV).
    Type: Application
    Filed: September 27, 2016
    Publication date: April 6, 2017
    Applicant: Myrexis, Inc.
    Inventors: Theodore J. Nitz, Christian Montalbetti, Richard Mears, Xinjie Gai, Edward Glenn
  • Patent number: 9505800
    Abstract: The present invention concerns novel pharmaceutically active triterpene derivatives, pharmaceutical compositions containing the same, their use as medicaments, and the use of the compounds for the manufacture of specific medicaments. The present invention also concerns a method of treatment involving administration of the compounds. Specifically, the compounds are derivatives of betulinic acid having substitutions at one or more of the C-3, C2-8 and C-19 positions as further described herein. The novel compounds are useful as antiretroviral agents. In particular, the novel compounds are useful for the treatment of Human Immunodeficiency Virus (HIV).
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: November 29, 2016
    Assignee: Myrexis, Inc.
    Inventors: Theodore J. Nitz, Christian Montalbetti, Richard Mears, Xinjie Gai, Edward Glenn
  • Publication number: 20120046291
    Abstract: The present invention concerns novel pharmaceutically active triterpene derivatives, pharmaceutical compositions containing the same, their use as medicaments, and the use of the compounds for the manufacture of specific medicaments. The present invention also concerns a method of treatment involving administration of the compounds. Specifically, the compounds are derivatives of betulinic acid having substitutions at one or more of the C-3, C2-8 and C-19 positions as further described herein. The novel compounds are useful as antiretroviral agents. In particular, the novel compounds are useful for the treatment of Human Immunodeficiency Virus (HIV).
    Type: Application
    Filed: November 2, 2007
    Publication date: February 23, 2012
    Inventors: Theodore J. Nitz, Christian Montalbetti, Richard Mears, Xinjie Gai, Edward Glenn
  • Publication number: 20090318714
    Abstract: The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a process for the manufacture of a compound of the formula VI, or a salt thereof, wherein R1, R2, R3 and R? are as defined in the specification, and processes of manufacturing this compound including intermediates.
    Type: Application
    Filed: November 6, 2006
    Publication date: December 24, 2009
    Inventors: John Mykytiuk, Ludovic Bonnet, Stephen Gorsuch, Osamu Ichihara, Richard Mears, Christine Richardson